Sirtuin 1 (SIRT1) Activation Mediates Sildenafil Induced Delayed Cardioprotection against Ischemia-Reperfusion Injury in Mice

Shalwala, Mona; Zhu, Shu-Guang; Das, Anindita; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.
January 2014
PLoS ONE;Jan2014, Vol. 9 Issue 1, p1
Academic Journal
Background: It has been well documented that phosphodiesterase-5 inhibitor, sildenafil (SIL) protects against myocardial ischemia/reperfusion (I-R) injury. SIRT1 is part of the class III Sirtuin family of histone deacetylases that deacetylates proteins involved in cellular stress response including those related to I-R injury. Objective/Hypothesis: We tested the hypothesis that SIL-induced cardioprotection may be mediated through activation of SIRT1. Methods: Adult male ICR mice were treated with SIL (0.7 mg/kg, i.p.), Resveratrol (RSV, 5 mg/kg, a putative activator of SIRT1 used as the positive control), or saline (0.2 mL). The hearts were harvested 24 hours later and homogenized for SIRT1 activity analysis. Results: Both SIL- and RSV-treated mice had increased cardiac SIRT1 activity (P<0.001) as compared to the saline-treated controls 24 hours after drug treatment. In isolated ventricular cardiomyocytes, pretreatment with SIL (1 µM) or RSV (1 µM) for one hour in vitro also upregulated SIRT1 activity (P<0.05). We further examined the causative relationship between SIRT1 activation and SIL-induced late cardioprotection. Pretreatment with SIL (or RSV) 24 hours prior to 30 min ischemia and 24 hours of reperfusion significantly reduced infarct size, which was associated with a significant increase in SIRT1 activity (P<0.05). Moreover, sirtinol (a SIRT1 inhibitor, 5 mg/kg, i.p.) given 30 min before I-R blunted the infarct-limiting effect of SIL and RSV (P<0.001). Conclusion: Our study shows that activation of SIRT1 following SIL treatment plays an essential role in mediating the SIL-induced cardioprotection against I-R injury. This newly identified SIRT1-activating property of SIL may have enormous therapeutic implications.


Related Articles

  • Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction. Thummasorn, Savitree; Apaijai, Nattayaporn; Kerdphoo, Sasiwan; Shinlapawittayatorn, Krekwit; Chattipakorn, Siriporn C.; Chattipakorn, Nipon // Cardiovascular Therapeutics;Dec2016, Vol. 34 Issue 6, p404 

    Aim Myocardial reperfusion via the re-canalization of occluded coronary arteries is gold standard for the treatment of acute myocardial infarction. However, reperfusion itself can cause myocardial damage due to increased reactive oxygen species ( ROS) production, a process known as...

  • Administration of minocycline ameliorates damage in a renal ischemia/reperfusion injury model. Dan Xia; Kezhen Shen; Weide Zhong; Hao Pan // Clinical & Investigative Medicine;Apr2011, Vol. 34 Issue 2, pE55 

    Purpose: The purpose of this study was to investigate the effects of minocycline on the renal dysfunction and injury caused by bilateral ischemia/reperfusion (I/R) of murine kidneys in vito. Methods: Male C57BL/6 mice were administered minocycline (45 mg/kg i.v.) or saline (0.9%, v/v, NaCl) 36...

  • A Mechanism Study Underlying the Protective Effects of Cyclosporine-A on Lung Ischemia-Reperfusion Injury. Li, Jian''an; Yan, Zhongya; Fang, Qianjin // Pharmacology;May2017, Vol. 100 Issue 1/2, p83 

    Aim: This study is aimed at validating the hypothesis that administration of cyclosporine-A (CsA) would be protective in lung ischemia-reperfusion (I/R) injury and in exploring the underlying mechanism. Methods: Rabbits were divided into 4 groups: the control, sham operation, I/R, and I/R with...

  • There is More to Life than Revascularization: Therapeutic Targeting of Myocardial Ischemia/Reperfusion Injury. Bell, Robert M.; Yellon, Derek M. // Cardiovascular Therapeutics;Dec2011, Vol. 29 Issue 6, pe67 

    Ischemic heart disease is the world's leading cause of death, and while clinical advances have meant improved and more rapid revascularization, there remains a significant element of myocardial death that thus far has not been successfully targeted in clinical practice, namely lethal reperfusion...

  • Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules. Nagata, Takanobu; Yasukawa, Hideo; Kyogoku, Sachiko; Oba, Toyoharu; Takahashi, Jinya; Nohara, Shoichiro; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Shimozono, Koutatsu; Pradervand, Sylvain; Hoshijima, Masahiko; Aoki, Hiroki; Fukumoto, Yoshihiro; Imaizumi, Tsutomu // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Myocardial ischemia reperfusion injury (IRI) adversely affects cardiac performance and the prognosis of patients with acute myocardial infarction. Although myocardial signal transducer and activator of transcription (STAT) 3 is potently cardioprotective during IRI, the inhibitory mechanism...

  • Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell. Liang, Yiran; Li, Yan; Kuang, Qing; Ding, Xiaoqiang; Wei, Zheng; Fang, Yi // American Journal of Nephrology;May2017, Vol. 45 Issue 5, p389 

    Background: Regulatory T (Treg) cells are a highly suppressive subset of CD4+ lymphocytes and have recently been proved to be crucial to suppress the inflammatory responses of ischemic kidney injury. CD28 superagonists (CD28sa) are monoclonal antibodies that preferentially expand...

  • Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Meng-Yu Wu; Giou-Teng Yiang; Wan-Ting Liao; Andy Po-Yi Tsai; Yeung-Leung Cheng; Pei-Wen Cheng; Chia-Ying Li; Chia-Jung Li // Cellular Physiology & Biochemistry (Karger AG);May2018, Vol. 46 Issue 4, p1650 

    Ischemia-reperfusion injury is associated with serious clinical manifestations, including myocardial hibernation, acute heart failure, cerebral dysfunction, gastrointestinal dysfunction, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome. Ischemia-reperfusion injury...

  • Cardioprotective Effects of MET-88, a Gamma-Butyrobetaine Hydroxylase Inhibitor, on Cardiac Dysfunction Induced by Ischemia/Reperfusion in Isolated Rat Hearts. Hayashi, Yukio; Tajima, Kiyotaka; Kirimoto, Tsukasa; Miyake, Hidekazu; Matsuura, Naosuke // Pharmacology;Nov2000, Vol. 61 Issue 4, p238 

    Inhibition of fatty acid metabolite accumulation may be beneficial for treatment of cardiac dysfunction induced by ischemia. MET-88, 3-(2,2,2-trimethylhydrazinium)propionate dihydrate, inhibits γ-butyrobetaine hydroxylase which catalyzes conversion of γ-butyrobetaine to carnitine. In this...

  • Protective Effect of Platelet Rich Plasma on Experimental Ischemia/Reperfusion Injury in Rat Ovary. Bakacak, Murat; Bostanci, Mehmet Suhha; İnanc, Fatma; Yaylali, asli; Serin, Salih; attar, Rukset; Yildirim, Gazi; Yildirim, Ozge Kizilkale // Gynecologic & Obstetric Investigation;May2016, Vol. 81 Issue 3, p225 

    Background/aims: Ovarian torsion is a common cause of local ischemic damage, reduced follicular activity and infertility. Platelet-rich plasma (PRP) contains growth factors with demonstrated cytoprotective properties; so we evaluated PRP efficacy in a rat ischemia/reperfusion (I/R)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics